These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 22095644)
121. Advances in structure determination by cryo-EM to unravel membrane-spanning pore formation. Scott H; Huang W; Bann JG; Taylor DJ Protein Sci; 2018 Sep; 27(9):1544-1556. PubMed ID: 30129169 [TBL] [Abstract][Full Text] [Related]
122. Molecular assembly of lethal factor enzyme and pre-pore heptameric protective antigen in early stage of translocation. Alisaraie L; Rouiller I J Mol Model; 2016 Jan; 22(1):7. PubMed ID: 26659402 [TBL] [Abstract][Full Text] [Related]
123. An overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsis. Ohanjanian L; Remy KE; Li Y; Cui X; Eichacker PQ Expert Opin Investig Drugs; 2015; 24(7):851-65. PubMed ID: 25920540 [TBL] [Abstract][Full Text] [Related]
124. Channel-forming bacterial toxins in biosensing and macromolecule delivery. Gurnev PA; Nestorovich EM Toxins (Basel); 2014 Aug; 6(8):2483-540. PubMed ID: 25153255 [TBL] [Abstract][Full Text] [Related]
125. A protective antigen mutation increases the pH threshold of anthrax toxin receptor 2-mediated pore formation. Dennis MK; Mogridge J Biochemistry; 2014 Apr; 53(13):2166-71. PubMed ID: 24641616 [TBL] [Abstract][Full Text] [Related]
126. Designing inhibitors of anthrax toxin. Nestorovich EM; Bezrukov SM Expert Opin Drug Discov; 2014 Mar; 9(3):299-318. PubMed ID: 24447197 [TBL] [Abstract][Full Text] [Related]
127. (19)F nuclear magnetic resonance and crystallographic studies of 5-fluorotryptophan-labeled anthrax protective antigen and effects of the receptor on stability. Chadegani F; Lovell S; Mullangi V; Miyagi M; Battaile KP; Bann JG Biochemistry; 2014 Feb; 53(4):690-701. PubMed ID: 24387629 [TBL] [Abstract][Full Text] [Related]
128. Nanoscopic surfactant behavior of the porin MspA in aqueous media. Perera AS; Wang H; Shrestha TB; Troyer DL; Bossmann SH Beilstein J Nanotechnol; 2013; 4():278-84. PubMed ID: 23766950 [TBL] [Abstract][Full Text] [Related]
129. Anthrax toxin protective antigen integrates poly-γ-D-glutamate and pH signals to sense the optimal environment for channel formation. Kintzer AF; Tang II; Schawel AK; Brown MJ; Krantz BA Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18378-83. PubMed ID: 23100533 [TBL] [Abstract][Full Text] [Related]
130. Comparison of the structural stability and dynamic properties of recombinant anthrax protective antigen and its 2-fluorohistidine-labeled analogue. Hu L; Joshi SB; Andra KK; Thakkar SV; Volkin DB; Bann JG; Middaugh CR J Pharm Sci; 2012 Nov; 101(11):4118-28. PubMed ID: 22911632 [TBL] [Abstract][Full Text] [Related]
131. A novel mechanism for antibody-based anthrax toxin neutralization: inhibition of prepore-to-pore conversion. Mechaly A; Levy H; Epstein E; Rosenfeld R; Marcus H; Ben-Arie E; Shafferman A; Ordentlich A; Mazor O J Biol Chem; 2012 Sep; 287(39):32665-73. PubMed ID: 22869370 [TBL] [Abstract][Full Text] [Related]
132. Bacillus anthracis edema factor substrate specificity: evidence for new modes of action. Göttle M; Dove S; Seifert R Toxins (Basel); 2012 Jul; 4(7):505-35. PubMed ID: 22852066 [TBL] [Abstract][Full Text] [Related]
133. Ratcheting up protein translocation with anthrax toxin. Feld GK; Brown MJ; Krantz BA Protein Sci; 2012 May; 21(5):606-24. PubMed ID: 22374876 [TBL] [Abstract][Full Text] [Related]